The testimony in a state court in Norman, Oklahoma, came during the
first trial to result from around 2,000 lawsuits by state and local
governments against opioid manufacturers.
Those cases seek to hold the companies responsible for an epidemic
the U.S. Centers for Disease Control and Prevention says led to a
record 47,600 opioid-related overdose deaths in 2017.
Holding back tears, Craig Box said he never suspected his son
Austin, a 22-year-old University of Oklahoma linebacker, was abusing
painkillers until after the young man was found unconscious at a
friend's house in 2011 and died at a hospital.
"We had no idea about the prevalence of these drugs and the dangers
of these drugs," Box said during testimony streamed online by
Courtroom View Network.
Box, who said he did not know what painkillers his son took, was
called as a witness to support Oklahoma Attorney General Mike
Hunter's assertion that J&J helped cause the epidemic by marketing
opioids as safe and effective for everyday pain while downplaying
their addictive qualities.
Oklahoma resolved similar claims against OxyContin maker Purdue
Pharma LP in March for $270 million and against Teva Pharmaceutical
Industries Ltd on Sunday for $85 million.
The state in the nonjury trial before Judge Thad Balkman has argued
J&J's actions created an oversupply of painkillers and a public
nuisance that will cost $17.5 billion to remedy over 30 years.
[to top of second column] |
J&J denies wrongdoing, arguing it properly marketed opioids and that
the state cannot prove it caused the epidemic. Its stock price
closed 4.2% lower at $131.33 on Wednesday.
To support their claims, the state's lawyers played a videotaped
deposition from Dr. Russell Portenoy, a physician who spent years
advocating the use of opioids for chronic pain while acting as a
paid speaker and consultant for drugmakers like J&J.
Portenoy, who agreed to testify for Oklahoma to avoid being sued
himself, said he was troubled by how drugmakers used his writings
and left out "balance" regarding opioids' risks.
"I've come to conclude their conduct in marketing without context,
without education, without risk, produced an increase in
inappropriate and unsafe prescribing that contributed to the public
health crisis," he said.
(Reporting by Nate Raymond in Boston; Editing by Bill Berkrot and
Jonathan Oatis)
[© 2019 Thomson Reuters. All rights
reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|